Future research endeavors will focus on integrating bone turnover markers, inflammatory factors (e.g., IL-6, TNF-α), and genetic data to elucidate the biological pathways linking depression, osteoporosis, and mortality. This evidence concerns the gene IL6 and depressive symptom measurement.